Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
9.38
+0.06 (0.64%)
Mar 19, 2026, 4:00 PM EDT - Market closed

Vir Biotechnology Revenue

In the year 2025, Vir Biotechnology had annual revenue of $68.56M, down -7.61%. Vir Biotechnology had revenue of $64.07M in the quarter ending December 31, 2025, with 417.78% growth.

Revenue (ttm)
$68.56M
Revenue Growth
-7.61%
P/S Ratio
19.09
Revenue / Employee
$186,801
Employees
367
Market Cap
1.31B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202568.56M-5.65M-7.61%
Dec 31, 202474.21M-11.98M-13.90%
Dec 31, 202386.18M-1.53B-94.67%
Dec 31, 20221.62B520.38M47.51%
Dec 31, 20211.10B1.02B1,334.39%
Dec 31, 202076.37M68.28M843.86%
Dec 31, 20198.09M-2.58M-24.16%
Dec 31, 201810.67M7.96M293.94%
Dec 31, 20172.71M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Ardelyx407.32M
Monte Rosa Therapeutics123.67M
Immatics56.67M
Zenas BioPharma10.00M
Taysha Gene Therapies9.77M
AtaiBeckley4.09M
Revenue Rankings